Five-year follow-up on the effect of oral acyclovir after penetrating keratoplasty for herpetic keratitis

Cornea

Volumn 28, Issue 8, 2009, Pages 843-845

  Jansen, Aateke F G ^a   Rijneveld, Wilhelmina J ^b   Remeijer, Lies ^a   Völker Dieben, Henny J M ^c   Eggink, Catharina A ^d   Geerards, Annette J M ^a   Mulder, Paul G H ^e   Rooij, Jeroen Van ^a  

^a ROTTERDAM EYE HOSPITAL   (Netherlands)

^b Westfries Gasthuis   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Acyclovir; Graft survival; Herpes simplex; Herpetic eye disease; Prophylaxis

Indexed keywords

ACICLOVIR; PLACEBO;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; EVENT FREE SURVIVAL; FOLLOW UP; GLAUCOMA SURGERY; GRAFT FAILURE; GRAFT INFECTION; GRAFT REJECTION; GRAFT SURVIVAL; HERPES SIMPLEX KERATITIS; HUMAN; INCIDENCE; MEDICAL RECORD; PENETRATING KERATOPLASTY; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; RECURRENT INFECTION; VASCULARIZATION; VISUAL ACUITY;

ACYCLOVIR; ADMINISTRATION, ORAL; ANTIVIRAL AGENTS; DRUG ADMINISTRATION SCHEDULE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KAPLAN-MEIERS ESTIMATE; KERATITIS, HERPETIC; KERATOPLASTY, PENETRATING; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; RECURRENCE; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 69749114331     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e318198399a     Document Type: Article

References (9)

1. Herpetic Eye Disease Study Group. Acyclovir for the prevention of recurrent herpes simplex virus eye disease. N Engl J Med. 1998;339:300-306.
2. Uchoa UBC, Rezende RA, Carrasco MA, et al. Long-term acyclovir use to prevent recurrent ocular herpes simplex virus infection. Arch Ophthalmol. 2003;121:1702-1704.
3. Tambasco FP, Cohen EJ, Nguyen LH, et al. Oral acyclovir after penetrating keratoplasty for herpes simplex keratitis. Arch Ophthalmol. 1999;117:445-449. (Pubitemid 29169637)
4. Moyes AL, Sugar A, Musch DC, et al. Antiviral therapy after penetrating keratoplasty for herpes simplex keratitis. Arch Ophthalmol. 1994;112:601-607. (Pubitemid 24155431)
5. Barney NP, Foster CS. A prospective randomized trial of oral acyclovir after penetrating keratoplasty for herpes simplex keratitis. Cornea. 1994;13(3):232-236.
6. Garcia DD, Farjo Q, Musch DC, et al. Effect of prophylactic oral acyclovir after penetrating keratoplasty for herpes simplex keratitis. Cornea. 2007;26:930-934. (Pubitemid 47329795)
7. Rooij van J, Rijneveld WJ, Remeijer L, et al. Effect of oral acyclovir after penetrating keratoplasty for herpetic keratitis. Ophthalmology. 2003;110:1916-1919.
8. Cobo M, Coster JD, Rice NSC, et al. Prognosis and management of corneal transplantation for herpetic keratitis. Arch Ophthalmol. 1980;98:1755-1759.
9. Lomholt JA, Baggesen K, Ehlers N. Recurrence and rejection rates following corneal transplantation for herpes simples keratitis. Acta Ophthalmol Scand. 1995:73:29-32.